This is a competing renewal of a training program that was initially funded in 1999. Since its inception, the primary goal of this training program has been to prepare promising pre-doctoral students for successful careers in nutritional sciences, with a focus on nutrition as a modulator of metabolic disease (obesity, diabetes), cancer, neurodegenerative disease, and cardiovascular disease. In this renewal we capitalize upon our unique academic structure of a recently merged Department of Pharmacology and Nutritional Sciences to provide a multi-disciplinary program where graduate students are trained to develop nutritional and/or pharmacologic approaches towards the prevention and treatment of chronic diseases. The need for highly trained scientists capable of conducting multidisciplinary research in this area has become critical with the increased prevalence of metabolic diseases in the U.S., and the growing recognition that metabolic disorders underlie chronic diseases including cancer, neurodegenerative disease, and cardiovascular disease. We envision that scientists who receive cross-training in nutrition and pharmacology through this multidisciplinary program will have the necessary skill set to tackle these common yet complex disease processes. Twenty-nine training faculty who routinely employ nutritional and/or pharmacologic approaches to understand the metabolic basis of disease will provide training around 4 theme areas (obesity/diabetes, cardiovascular disease, cancer, neuroscience/aging). The goals of the Multidisciplinary Approaches for Metabolic Diseases Training Program are to provide support to a talented and diverse population of graduate students through stipends and individual development plans (IDPs) to prepare them for biomedical careers in the area of metabolic diseases; to provide innovative, multidisciplinary education to promote the essential skills for conducting outstanding research using nutrition and pharmacology-based approaches; to provide a core faculty of established and productive researchers who will serve as mentors and role models for the trainees; to provide a broad-based yet cohesive research environment for trainees, thus fostering further interdisciplinary research; and to provide training in the ethcal conduct of high quality research.

Public Health Relevance

Disorders in metabolism are a common feature of most chronic diseases, especially those on the rise in prevalence in the US. We propose to train future scientists to identify ways to use pharmacological (drugs) and nutritional approaches to prevent and treat metabolic disease based-disorders, including obesity/diabetes, cancer, cardiovascular disease and neurodegenerative disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
2T32DK007778-16
Application #
8851863
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
2000-08-15
Project End
2020-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
16
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Pharmacology
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Hampton, Kaia K; Anderson, Katie; Frazier, Hilaree et al. (2018) Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1. Mol Pharmacol 94:665-673
Lee, Jennifer; Yanckello, Lucille M; Ma, David et al. (2018) Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer's Disease. Front Aging Neurosci 10:225
Wang, Yongchao; Wang, Xin; Li, Hui et al. (2018) Binge ethanol exposure induces endoplasmic reticulum stress in the brain of adult mice. Toxicol Appl Pharmacol 356:172-181
Hargis, Kendra; Buechel, Heather M; Popovic, Jelena et al. (2018) Acute psychosocial stress in mid-aged male rats causes hyperthermia, cognitive decline, and increased deep sleep power, but does not alter deep sleep duration. Neurobiol Aging 70:78-85
Frazier, H N; Anderson, K L; Maimaiti, S et al. (2018) Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents. Neurochem Res :
Ma, David; Wang, Amy C; Parikh, Ishita et al. (2018) Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. Sci Rep 8:6670
Petriello, Michael C; Brandon, J Anthony; Hoffman, Jessie et al. (2018) Dioxin-like PCB 126 Increases Systemic Inflammation and Accelerates Atherosclerosis in Lean LDL Receptor-Deficient Mice. Toxicol Sci 162:548-558
Bayoumi, Ahmed S; Park, Kyoung-Mi; Wang, Yongchao et al. (2018) A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes. J Mol Cell Cardiol 114:72-82
Zhu, Xingguo; Hu, Tianxiang; Ho, Meng Hsuan et al. (2017) Hydroxyurea differentially modulates activator and repressors of ?-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness. Haematologica 102:1995-2004
Helsley, Robert N; Zhou, Changcheng (2017) Epigenetic impact of endocrine disrupting chemicals on lipid homeostasis and atherosclerosis: a pregnane X receptor-centric view. Environ Epigenet 3:

Showing the most recent 10 out of 75 publications